November 27, 2023 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, has announced additions to its Oncology Program Board.
The SCRS Oncology Program is dedicated to advancing the sustainability and effectiveness of oncology sites by identifying their unique needs and creating strategic resources to address these challenges. Through collaboration with corporate and site partners, our mission is to foster a dynamic environment that encourages the identification and development of solutions for the oncology research community.
The newly appointed members were carefully selected based on their extensive expertise and rich experience in the field of oncology research. The recently added members of the Oncology Board include:
Jimmy Bechtel, SCRS VP of Site Engagement, shared, “As SCRS continues its mission to advance the sustainability and effectiveness of oncology sites, the unique insights and expertise of our newly appointed members will play a pivotal role in identifying and developing resources that will benefit the entire oncology research community. Their dedication to creating opportunities for innovation and excellence in oncology research will undoubtedly shape the future of the program.”
To learn more about the SCRS Oncology Program visit myscrs.org/about/scrs-oncology-program.
About the Society for Clinical Research Sites
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.